News for September 2015

News Archive

Scripps Florida Scientists Identify Promising Drug Candidate to Treat Chronic Itch that Avoids Side Effects Scripps Florida Scientists Identify Promising Drug Candidate to Treat Chronic Itch that Avoids Side Effects

If you have an itch, you have to scratch it. But that’s a problem for people with a condition called “chronic intractable itch,” where that itchy sensation never goes away—a difficult-to-treat condition closely associated with dialysis and renal failure.

The Current issue of “The view from here” discusses Epigenetics The Current issue of “The view from here” discusses Epigenetics

The topic of this month’s newsletter from Drug Discovery Today is Epigenetics.

New discovery offers cure by starving cancer cells New discovery offers cure by starving cancer cells

Scientists know that most cancer cells use glucose to fuel their uncontrolled growth and now an international team of researchers has identified a protein which if switched off could stop the disease in its tracks.

TSRI and UC San Diego Launch New Consortium to Create ‘Virtual Cell’ TSRI and UC San Diego Launch New Consortium to Create ‘Virtual Cell’

Drawing on complementary strengths of two San Diego institutions, The Scripps Research Institute (TSRI) and the University of California, San Diego (UC San Diego) have formed a new consortium with a big mission: to map cells in space and time.

Embarrassing Bodies’ Dr Dawn Harper delivers inspiring message to would-be scientists Embarrassing Bodies’ Dr Dawn Harper delivers inspiring message to would-be scientists

New survey data shows Science most popular school subject; UCB’s Work In Science Week underpins commitment to motivating young people to pursue career in science

Patent-blocking strategies to give developing nations access to cheaper, safer drugs may stunt research Patent-blocking strategies to give developing nations access to cheaper, safer drugs may stunt research

The patent-blocking strategies being used by some international advocacy groups to promote access to cheaper drugs in developing nations can be seen to be good thing; however, it is important that issues concerning the availability of the drug and the pricing of the drug are kept separate. If there is pressure on patent courts to decide against awarding a patent to a drug company because there is a desire to have the drug at a low price, this results in a conflict of interests and will fundamentally invalidate the patent system. If such situations occur they could stunt vital drug research programmes.

Health Leaders Gather To Tackle Antibiotic Crisis Health Leaders Gather To Tackle Antibiotic Crisis

Leading economist Lord Jim O’Neill has been confirmed as the keynote speaker at a flagship conference focused on finding new ways to tackle the global threat to public health posed by antibiotic resistance.